P3 Health Partners Inc. revenue
P3 Health Partners Inc.'s revenue was $1.46bn in fiscal 2025, down 2.8% on the year before. Since fiscal 2019 ($145m) it has grown at a compound 46.9% a year. Over the last twelve months it was $1.50bn.
Revenue history
Where the revenue comes from
| Line of business | Revenue | YoY |
|---|---|---|
| Capitated Revenue | $1.4B | ▼ 3.7% |
| Health Care Patient Service | $30.1M | ▲ 78.6% |
| Health Care Other | $30.1M | ▲ 78.6% |
| Health Care Incentive Fees | $16.2M | ▲ 4456.7% |
| Health Care Care Coordination Management Fees | $10.8M | ▲ 2.5% |
| Health Care Clinical Fees Insurance Revenue | $3.1M | ▼ 48.5% |
These categories overlap or exclude eliminations, so shares aren't shown.
From P3 Health Partners Inc.'s 10-K filed March 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| P3 Health Partners Inc. | $1.50bn | 2.8% | 9.7% |
| Addus Homecare Corp | $1.48bn | 15.9% | 13.9% |
| Healthequity, Inc. | $1.36bn | 7.3% | 13.2% |
| Progyny, Inc. | $1.31bn | 5.5% | 11.0% |
| Guardant Health, Inc. | $1.18bn | 42.7% | 32.4% |
| Pennant Group, Inc. | $1.10bn | 37.9% | 30.0% |
Compare with peers
- Addus Homecare Corp revenue
- Healthequity, Inc. revenue
- Progyny, Inc. revenue
- Guardant Health, Inc. revenue
- Pennant Group, Inc. revenue
Head to head: ADUS vs PIIIHQY vs PIIIPGNY vs PIII
More: Health Care Services stocks compared, Health Care sector, rankings of US companies